These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 24846123)
1. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells. Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123 [TBL] [Abstract][Full Text] [Related]
2. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection. Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251 [TBL] [Abstract][Full Text] [Related]
3. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
4. A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner. Bálint Š; Lopes FB; Davis DM Sci Signal; 2018 Apr; 11(525):. PubMed ID: 29636390 [TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914 [TBL] [Abstract][Full Text] [Related]
6. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318 [TBL] [Abstract][Full Text] [Related]
7. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2. Uhlenbrock F; van Andel E; Andresen L; Skov S Mol Immunol; 2015 Aug; 66(2):418-27. PubMed ID: 25983110 [TBL] [Abstract][Full Text] [Related]
8. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260 [TBL] [Abstract][Full Text] [Related]
9. Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ? Giuliani E; Vassena L; Cerboni C; Doria M Curr Drug Targets; 2016; 17(1):54-64. PubMed ID: 26122035 [TBL] [Abstract][Full Text] [Related]
10. Altered NK-cell compartment and dysfunctional NKG2D/NKG2D-ligand axis in patients with ataxia-telangiectasia. Desimio MG; Finocchi A; Di Matteo G; Di Cesare S; Giancotta C; Conti F; Chessa L; Piane M; Montin D; Dellepiane M; Rossi P; Cancrini C; Doria M Clin Immunol; 2021 Sep; 230():108802. PubMed ID: 34298181 [TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Heinemann A; Zhao F; Pechlivanis S; Eberle J; Steinle A; Diederichs S; Schadendorf D; Paschen A Cancer Res; 2012 Jan; 72(2):460-71. PubMed ID: 22102694 [TBL] [Abstract][Full Text] [Related]
12. Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA: Dual role in cancer immunosurveillance. Vulpis E; Loconte L; Peri A; Molfetta R; Caracciolo G; Masuelli L; Tomaipitinca L; Peruzzi G; Petillo S; Petrucci MT; Fazio F; Simonelli L; Fionda C; Soriani A; Cerboni C; Cippitelli M; Paolini R; Bernardini G; Palmieri G; Santoni A; Zingoni A J Extracell Vesicles; 2022 Jan; 11(1):e12176. PubMed ID: 34973063 [TBL] [Abstract][Full Text] [Related]
13. Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype. Brennan K; McSharry BP; Keating S; Petrasca A; O'Reilly VP; Keane J; Doherty DG; Gardiner CM Hum Immunol; 2016 Oct; 77(10):876-885. PubMed ID: 27349945 [TBL] [Abstract][Full Text] [Related]
14. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H; Kim J; Cosman D; Choi I Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway. Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340 [TBL] [Abstract][Full Text] [Related]
16. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762 [TBL] [Abstract][Full Text] [Related]
17. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell. Bae DS; Hwang YK; Lee JK Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008 [TBL] [Abstract][Full Text] [Related]
18. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211 [TBL] [Abstract][Full Text] [Related]
19. Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on Frazao A; Colombo M; Fourmentraux-Neves E; Messaoudene M; Rusakiewicz S; Zitvogel L; Vivier E; Vély F; Faure F; Dréno B; Benlalam H; Bouquet F; Savina A; Pasmant E; Toubert A; Avril MF; Caignard A Cancer Immunol Res; 2017 Jul; 5(7):582-593. PubMed ID: 28576831 [TBL] [Abstract][Full Text] [Related]
20. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]